Table 1.
Association of atrial fibrillation history with unadjusted and adjusted rate ratios for clinical outcomes (reference group is patients with no history of atrial fibrillation)
Outcome | Unadjusted RR (95% CI) | P value | Adjusted RR (95% CI)*† | P value |
All-cause mortality | 2.16 (1.57 to 2.98) | <0.001 | 0.98 (0.70 to 1.38) | 0.93 |
Bleeding event requiring hospitalisation | 2.61 (1.58 to 4.30) | <0.001 | 1.64 (0.96 to 2.82) | 0.07 |
All-cause hospitalisation | 1.76 (1.50 to 2.06) | <0.001 | 1.25 (1.06 to 1.46) | 0.008 |
Primary composite | 1.61 (1.26 to 2.06) | <0.001 | 0.92 (0.71 to 1.20) | 0.53 |
Secondary composite | 2.07 (1.57 to 2.73) | <0.001 | 1.15 (0.86 to 1.55) | 0.35 |
Primary composite=all-cause mortality, myocardial infarction, stroke, unstable angina with urgent revascularisation. Secondary composite=cardiovascular mortality, myocardial infarction, stroke.
*Composite, all-cause mortality and bleeding requiring hospitalisation outcomes adjusted for variables in the TIGRIS risk index model: age ≥65 years, diabetes, second prior MI, chronic kidney disease, heart failure, peripheral artery disease, major bleed, medical management of index MI, diuretics, region and country as random effects.
†All-cause hospitalisation outcome (from 7170 patients with complete hospitalisation data) adjusted for predictors of all-cause hospitalisation: cardiovascular event requiring hospital stay 6 months before enrolment, diuretic, chronic kidney disease, age ≥65 years, second prior MI, diabetes, history of cancer, permanent pacemaker, history of COPD, systolic blood pressure, implantable cardioverter defibrillator, history of major bleed, history of angina, cardiologist visit 6 months before enrolment, region, statin or other lipid-lowering drug and history of anaemia.
COPD, chronic obstructive pulmonary disease; CV, cardiovascular; MI, myocardial infarction; RR, rate ratio; TIGRIS, long Term rIsk, clinical manaGement and healthcare Resource utilization of stable coronary artery dISease registry.